Detecting Methotrexate in Pediatric Patients Using Artificial Neural Networks
Methotrexate is an antimetabolic agent with proliferative and immunosuppressive activity. It has been demonstrated to be an effective treatment for acute lymphoblastic leukemia (ALL) in children. However, there is evidence of an association between methotrexate and toxicity risks, which influences t...
Saved in:
Main Authors: | Alejandro Medina Santiago, Jorge Iván Bermúdez Rodríguez, Jorge Antonio Orozco Torres, Julio Alberto Guzmán Rabasa, José Manuel Villegas Izaguirre, Gladys Falconi Alejandro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/15/1/306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug‐Induced Cauda Equina Syndrome in an 8‐Year‐Old Boy With Acute Lymphoblastic Leukemia: An Uncommon Case Report
by: Marzieh Babaee, et al.
Published: (2025-01-01) -
Incidence of secondary malignancies in Polish children treated for acute lymphoblastic leukemia according to the ALL-IC BFM 2002 protocol
by: Kamila Wypyszczak, et al.
Published: (2024-12-01) -
Impact of ABO gene polymorphism and von Willebrand factor on genetic susceptibility to acute lymphoblastic leukemia in Egyptian pediatric patients
by: Elsayed I. Salim, et al.
Published: (2025-01-01) -
A young adult patient with Philadelphia positive acute lymphoblastic leukemia presenting with extreme hyperleukocytosis
by: Gulten Tikit, et al.
Published: (2025-01-01) -
Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study
by: Eri Ushida, et al.
Published: (2025-01-01)